Elham Askari

1.3k total citations · 1 hit paper
29 papers, 651 citations indexed

About

Elham Askari is a scholar working on Infectious Diseases, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Elham Askari has authored 29 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 8 papers in Oncology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Elham Askari's work include Multiple Myeloma Research and Treatments (6 papers), Antifungal resistance and susceptibility (5 papers) and COVID-19 Clinical Research Studies (5 papers). Elham Askari is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Antifungal resistance and susceptibility (5 papers) and COVID-19 Clinical Research Studies (5 papers). Elham Askari collaborates with scholars based in Iran, Spain and Netherlands. Elham Askari's co-authors include Amrita Krishnan, Jeffery S. Russell, María‐Victoria Mateos, Jesús G. Berdeja, Raluca Verona, Brandi Hilder, Albert Oriol, Niels W.C.J. van de Donk, Monique C. Minnema and Suzette Girgis and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Elham Askari

25 papers receiving 638 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma

2022 350 citations Monique C. Minnema, Jesús G. Berdeja et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elham Askari Iran	10	345	321	252	163	115	29	651
Vladimir Vainstein Israel	15	283 0.8×	236 0.7×	226 0.9×	112 0.7×	105 0.9×	51	723
Tong Wu China	14	263 0.8×	468 1.5×	96 0.4×	144 0.9×	253 2.2×	66	853
Leyla Shune United States	13	410 1.2×	343 1.1×	210 0.8×	27 0.2×	99 0.9×	107	688
Philipp Schütt Germany	13	239 0.7×	180 0.6×	101 0.4×	55 0.3×	197 1.7×	23	594
Hamza Hashmi United States	11	274 0.8×	198 0.6×	177 0.7×	30 0.2×	76 0.7×	102	476
W. Grimminger Germany	6	144 0.4×	334 1.0×	96 0.4×	86 0.5×	61 0.5×	6	533
Sameem Abedin United States	18	220 0.6×	378 1.2×	332 1.3×	25 0.2×	187 1.6×	68	890
Matthew Streetly United Kingdom	17	523 1.5×	799 2.5×	586 2.3×	62 0.4×	213 1.9×	52	1.2k
Nicolaus Kröger Germany	16	271 0.8×	401 1.2×	269 1.1×	47 0.3×	306 2.7×	65	817
Nobuhiro Hiramoto Japan	13	151 0.4×	123 0.4×	82 0.3×	53 0.3×	63 0.5×	72	488

Countries citing papers authored by Elham Askari

Since Specialization

Citations

This map shows the geographic impact of Elham Askari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elham Askari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elham Askari more than expected).

Fields of papers citing papers by Elham Askari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elham Askari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elham Askari. The network helps show where Elham Askari may publish in the future.

Co-authorship network of co-authors of Elham Askari

This figure shows the co-authorship network connecting the top 25 collaborators of Elham Askari. A scholar is included among the top collaborators of Elham Askari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elham Askari. Elham Askari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Askari, Elham, Moslem Savari, & Mitra Rezaei. (2025). Application of construal level theory in identifying factors affecting individual decision-making in implementing flood protection measures in rural areas of Iran. Scientific Reports. 15(1). 29873–29873.

Askari, Elham, Moslem Savari, & Mitra Rezaei. (2025). Factors affecting the application of protective measures before flood occurrence among local communities in Iran. Climate Risk Management. 49. 100730–100730. 2 indexed citations

Askari, Elham, Moslem Savari, & Mitra Rezaei. (2025). Analysis and modeling of key factors in implementing pre-flood protection measures in local communities in Iran. Environmental and Sustainability Indicators. 27. 100838–100838. 1 indexed citations

Abin, Ahmad Ali, et al.. (2025). ¹⁸F-FDG PET radiomics and machine learning for virtual biopsy and treatment decisions in lymphoma: a multicenter study. Physical and Engineering Sciences in Medicine. 49(1). 381–395.

Rubia, Javier de la, Rafael Alonso, Elham Askari, et al.. (2023). Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma: Results of the Compassionate Use or the Expanded Access Program in Spain. Cancers. 15(11). 2964–2964. 9 indexed citations

Tabarsi, Payam, et al.. (2023). The impact of COVID-19 on TB in Iran: An illustrative study. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 31. 100357–100357. 1 indexed citations

Askari, Elham, et al.. (2022). Bronchial wall necrosis secondary to mucormycosis following SARS-Cov2 infection: A case report. SHILAP Revista de lepidopterología. 17(9). 2956–2959. 1 indexed citations

Tabarsi, Payam, Mihan Pourabdollah Toutkaboni, Mehdi Kazempour Dizaji, et al.. (2022). The Prevalence of Carbapenemase Genes in Carbapenem-resistant Gram-negative Bacilli, Masih Daneshvari Hospital, Tehran, Iran, 2019-2020. Iranian Journal of Medical Microbiology. 16(6). 573–580. 4 indexed citations

Farzanegan, Behrooz, Naghmeh Bahrami, Adnan Khosravi, et al.. (2021). Down-Expression of miRNA-98 and Over-Expression of miRNA-9 Can Result in Inadequate Immune System Response against Lung Cancer. Biointerface Research in Applied Chemistry. 11(6). 13893–13902. 3 indexed citations

10.

Mirsadraee, Saeed, Mihan Pourabdollah Toutkaboni, Mehrdad Bakhshayesh Karam, et al.. (2021). Radiological and Laboratory Findings of Patients with COVID-19 Infection at the Time of Admission. Iranian journal of pathology. 16(2). 137–143. 2 indexed citations

11.

Askari, Elham, Sara Rodríguez, & Ramón García‐Sánz. (2021). Waldenström’s Macroglobulinemia: An Exploration into the Pathology and Diagnosis of a Complex B-Cell Malignancy. Journal of Blood Medicine. Volume 12. 795–807. 6 indexed citations

12.

Krishnan, Amrita, Monique C. Minnema, Jesús G. Berdeja, et al.. (2021). Updated Phase 1 Results from MonumenTAL-1: First-in-Human Study of Talquetamab, a G Protein-Coupled Receptor Family C Group 5 Member D x CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma. Blood. 138(Supplement 1). 158–158. 40 indexed citations

13.

Devesa, Ana, A. M. Lázaro, Elham Askari, et al.. (2021). Prevalence of Transthyretin Amyloidosis in Patients with Heart Failure and No Left Ventricular Hypertrophy. ESC Heart Failure. 8(4). 2856–2865. 33 indexed citations

14.

Askari, Elham, Mihan Pourabdollah Toutkaboni, Sara Haseli, et al.. (2021). Not all that is miliary is tuberculosis: Metastatic medullary thyroid carcinoma mimicking miliary tuberculosis. SHILAP Revista de lepidopterología. 9(5). e04231–e04231. 1 indexed citations

15.

Mohamadnia, Abdolreza, Zahra Salehi, Payam Tabarsi, et al.. (2020). Molecular identification, phylogenetic analysis and antifungal susceptibility patterns of Aspergillus nidulans complex and Aspergillus terreus complex isolated from clinical specimens. Journal de Mycologie Médicale. 30(3). 101004–101004. 6 indexed citations

16.

Toutkaboni, Mihan Pourabdollah, Elham Askari, Nastaran Khalili, et al.. (2020). Demographics, laboratory parameters and outcomes of 1061 patients with coronavirus disease 2019: a report from Tehran, Iran. New Microbes and New Infections. 38. 100777–100777. 9 indexed citations

17.

Manso, Rebeca, Olga Balagué, Cristina Chamizo, et al.. (2020). Lymphoplasmacytic lymphoma associated with diffuse large B-cell lymphoma: Progression or divergent evolution?. PLoS ONE. 15(11). e0241634–e0241634. 7 indexed citations

18.

Chari, Ajai, Jesús G. Berdeja, Albert Oriol, et al.. (2020). A Phase 1, First-in-Human Study of Talquetamab, a G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) x CD3 Bispecific Antibody, in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM). Blood. 136(Supplement 1). 40–41. 48 indexed citations

19.

Khalighinejad, Navid, et al.. (2014). Immunologic and psychologic parameters associated with geographic tongue. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 118(1). 68–71. 31 indexed citations

20.

Guerrero, Manuel L. Fernández, et al.. (2011). Emerging infectious endocarditis due to Scedosporium prolificans: a model of therapeutic complexity. European Journal of Clinical Microbiology & Infectious Diseases. 30(11). 1321–1324. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact